A recent study published in Small addresses the persistent difficulty of treating refractory melanoma, an aggressive form of skin cancer that often does not respond to existing therapies.
Although diagnostic tools and immunotherapies have improved in recent years, a substantial number of patients remain unresponsive to current treatment options, highlighting the need for alternative therapeutic approaches.
Image Credit: New Africa/Shutterstock.com
The researchers in this study explore a strategy that combines intracellular stress targeting with immune modulation.
Specifically, they investigate the co-administration of two hydrophobic drugs: copper diethyldithiocarbamate (CuET), which inhibits the p97-UFD1-NPL4 protein complex to induce endoplasmic reticulum (ER) stress and promote cytotoxicity; and 6-bromo-indirubin-3′-oxime (BIO), a GSK3 inhibitor that can influence inflammatory pathways and tumor cell growth.
Background
Melanoma becomes particularly difficult to treat once it develops resistance to standard therapies. Tumor cells can avoid immune detection and resist cell death mechanisms, reducing the effectiveness of many treatments. This study focuses on targeting both cellular stress pathways and immune checkpoints as a dual approach.
CuET disrupts protein degradation by inhibiting the p97-UFD1-NPL4 complex, leading to ER stress and apoptosis, especially in cancer cells already under stress. BIO, as a GSK3 inhibitor, affects β-catenin signaling and the production of inflammatory cytokines, which can help reshape the tumor microenvironment to enhance immune recognition.
Because both CuET and BIO are hydrophobic, systemic delivery is a challenge. To address this, the researchers developed liposome-polymer nanoparticles (LPNs) capable of encapsulating the drugs, improving their solubility, delivery precision, and release control.
The Current Study
The research included both in vitro and in vivo experiments to evaluate the drug delivery system. The team first established the optimal molar ratio of CuET to BIO using several melanoma cell lines, including B16F10 and YUMM1.7, along with their variants.
The drugs were co-loaded into LPNs made from phospholipids and stabilized with poly(vinylpyrrolidone), which improved their compatibility in aqueous environments. Particle size, surface charge, encapsulation efficiency, and stability were analyzed using dynamic light scattering and electron microscopy.
Cellular uptake and cytotoxicity were assessed using viability assays (including the sulforhodamine B method) in both two-dimensional cell cultures and three-dimensional tumor spheroids. Additional analyses (such as immunofluorescence, Western blotting, and flow cytometry) were used to track changes in β-catenin levels, immune marker expression, and T cell activation.
In vivo, the LPNs were tested in mouse models of melanoma, again using the B16F10 and YUMM1.7 cell lines, which exhibit features of therapy-resistant disease. Tumor growth, metastasis, and treatment-related toxicity were monitored through imaging, histological evaluation, and blood analysis.
Results and Discussion
The co-loaded nanoparticles demonstrated consistent particle size (100–150 nm), high encapsulation efficiency, and stability under physiological conditions. In vitro, the combination therapy showed a greater reduction in melanoma cell viability than either drug alone, indicating a synergistic cytotoxic effect.
One notable finding was BIO’s ability to counteract the accumulation of β-catenin induced by CuET. This suggests that the drug pair can modulate intracellular signaling in a way that may limit tumor proliferation and reduce metastatic potential. The combination also increased markers of ER stress and apoptosis, supporting the idea that the two drugs operate through complementary mechanisms.
Beyond direct effects on tumor cells, the study also examined the immune-related impact of the treatment. The combination therapy led to reduced expression of PD-L1 on tumor cells, potentially improving immune cell recognition. Flow cytometry revealed increased levels of immune activation markers such as CD69, along with changes in PD-1 expression on T cells. CuET alone increased PD-1 levels, a response that was moderated by the addition of BIO.
CuET was also found to suppress IL-2 secretion from activated T cells, directly influencing immune cell function. These results suggest that the therapy engages both tumor-intrinsic and immune-modulatory pathways, contributing to a more comprehensive anti-tumor response.
In vivo, treatment with the liposome-polymer nanoparticles led to a significant decrease in tumor size—about 47 % in B16F10 models and over 75 % in YUMM1.7 models. Importantly, this effect was achieved without significant toxicity. Mice maintained stable body weight, and blood and histological analyses showed no signs of liver or kidney damage.
Overall, the findings support the use of this nanocarrier system for delivering hydrophobic drug combinations, offering effective tumor suppression with a favorable safety profile.
Conclusion
This study presents a liposome-polymer nanoparticle system designed to deliver CuET and BIO in combination as a potential treatment for resistant melanoma. The formulation demonstrated stability, effective tumor suppression in vitro and in vivo, and a favorable safety profile.
By targeting ER stress, β-catenin signaling, and immune checkpoint pathways, the approach offers a multi-faceted therapeutic option for melanoma that has not responded to existing treatments.
Further research may explore the use of similar delivery systems for other drug combinations, particularly in cancers where treatment resistance remains a significant challenge.
Journal Reference
Paun R. A., et al. (2025). Liposome-Polymer Nanoparticles Loaded with Copper Diethyldithiocarbamate and 6-Bromo-Indirubin-3′-Oxime Enable the Treatment of Refractive Melanoma. Small, DOI: 10.1002/smll.202409012, https://onlinelibrary.wiley.com/doi/10.1002/smll.202409012
News
Nanoparticle-Based Combination Therapy for Resistant Melanoma
A recent study published in Small addresses the persistent difficulty of treating refractory melanoma, an aggressive form of skin cancer that often does not respond to existing therapies. Although diagnostic tools and immunotherapies have improved in [...]
Our DNA May Evolve Much Faster Than Previously Thought
Rapidly mutating DNA regions were mapped using a multi-generational family and advanced sequencing tools. Understanding how human DNA changes over generations is crucial for estimating genetic disease risks and tracing our evolutionary history. However, some of [...]
AI therapy may help with mental health, but innovation should never outpace ethics
Mental health services around the world are stretched thinner than ever. Long wait times, barriers to accessing care and rising rates of depression and anxiety have made it harder for people to get timely help. As a result, governments and health care providers are [...]
Global life expectancy plunges as WHO warns of deepening health crisis Post-COVID
The World Health Organization (WHO) has sounded the alarm on the long-term health repercussions of the COVID-19 pandemic in its newly released World Health Statistics Report 2025. The report reveals a staggering decline in global [...]
Researchers map brain networks involved in word retrieval
How are we able to recall a word we want to say? This basic ability, called word retrieval, is often compromised in patients with brain damage. Interestingly, many patients who can name words they [...]
Melting Ice Is Changing the Color of the Ocean – Scientists Are Alarmed
Melting sea ice changes not only how much light enters the ocean, but also its color, disrupting marine photosynthesis and altering Arctic ecosystems in subtle but profound ways. As global warming causes sea ice in the [...]
Your Washing Machine Might Be Helping Antibiotic-Resistant Bacteria Spread
A new study reveals that biofilms in washing machines may contain potential pathogens and antibiotic resistance genes, posing possible risks for laundering healthcare workers’ uniforms at home. Washing healthcare uniforms at home could be [...]
Scientists Discover Hidden Cause of Alzheimer’s Hiding in Plain Sight
Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help treat the disease early by targeting the gene’s hidden function. A recent study has revealed that a gene previously [...]
How Brain Cells Talk: Inside the Complex Language of the Human Mind
Introduction The human brain contains nearly 86 billion neurons, constantly exchanging messages like an immense social media network, but neurons do not work alone – glial cells, neurotransmitters, receptors, and other molecules form a vast [...]
Oxford study reveals how COVID-19 vaccines prevent severe illness
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated. Despite the global success of [...]
Annual blood test could detect cancer earlier and save lives
A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart progression to advanced disease while the malignancy is still at an early [...]
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
